FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976264755> ?p ?o ?g. }

• W1976264755 endingPage "99" @default.
• W1976264755 startingPage "95" @default.
• W1976264755 abstract "ObjectiveWe investigated an association between adiponectin and long-term survival in patients requiring an arterial bypass operation for peripheral arterial disease.MethodsAn enzyme-linked immunosorbent assay kit was used to measure plasma adiponectin levels in 49 patients (38 men, 11 women) before they underwent an arterial bypass operation. Median patient age was 70 years (range, 49-90 years). The study excluded patients with hemodialysis requirement, heart failure, malignant neoplasm, or collagen disease. The symptoms at the first visit were severe intermittent claudication in 27 patients (55%) and critical limb ischemia with rest pain or ulcer, or both, in 22 (45%).ResultsPlasma adiponectin levels were a mean 7.8 ± 5.3 μg/mL (range, 1.0-25.2 μg/mL). Multiple regression analyses revealed that plasma adiponectin was positively correlated with age (r = 0.49, P = .0003) and negatively correlated with body mass index (r = −0.51, P = .0002) and systolic blood pressure (r = −0.41, P = .0059). The Cox proportional hazards model revealed that plasma adiponectin (hazard ratio, 1.30; P = .03) and critical limb ischemia (hazard ratio, 16.67; P = .047) were significant independent predictors of patient survival after a bypass operation.ConclusionPlasma adiponectin could be indicative of mortality after a bypass operation for patients with advanced peripheral arterial disease. We investigated an association between adiponectin and long-term survival in patients requiring an arterial bypass operation for peripheral arterial disease. An enzyme-linked immunosorbent assay kit was used to measure plasma adiponectin levels in 49 patients (38 men, 11 women) before they underwent an arterial bypass operation. Median patient age was 70 years (range, 49-90 years). The study excluded patients with hemodialysis requirement, heart failure, malignant neoplasm, or collagen disease. The symptoms at the first visit were severe intermittent claudication in 27 patients (55%) and critical limb ischemia with rest pain or ulcer, or both, in 22 (45%). Plasma adiponectin levels were a mean 7.8 ± 5.3 μg/mL (range, 1.0-25.2 μg/mL). Multiple regression analyses revealed that plasma adiponectin was positively correlated with age (r = 0.49, P = .0003) and negatively correlated with body mass index (r = −0.51, P = .0002) and systolic blood pressure (r = −0.41, P = .0059). The Cox proportional hazards model revealed that plasma adiponectin (hazard ratio, 1.30; P = .03) and critical limb ischemia (hazard ratio, 16.67; P = .047) were significant independent predictors of patient survival after a bypass operation. Plasma adiponectin could be indicative of mortality after a bypass operation for patients with advanced peripheral arterial disease." @default.
• W1976264755 created "2016-06-24" @default.
• W1976264755 creator A5034179596 @default.
• W1976264755 creator A5038834794 @default.
• W1976264755 creator A5041987541 @default.
• W1976264755 creator A5078212994 @default.
• W1976264755 creator A5086558284 @default.
• W1976264755 creator A5090747574 @default.
• W1976264755 date "2009-07-01" @default.
• W1976264755 modified "2023-10-15" @default.
• W1976264755 title "Plasma adiponectin as a predictive factor of survival after a bypass operation for peripheral arterial disease" @default.
• W1976264755 cites W1970377075 @default.
• W1976264755 cites W1971068956 @default.
• W1976264755 cites W1981261500 @default.
• W1976264755 cites W1993459753 @default.
• W1976264755 cites W2001727439 @default.
• W1976264755 cites W2020949125 @default.
• W1976264755 cites W2027045198 @default.
• W1976264755 cites W2045184477 @default.
• W1976264755 cites W2065697164 @default.
• W1976264755 cites W2072085645 @default.
• W1976264755 cites W2072526806 @default.
• W1976264755 cites W2088840838 @default.
• W1976264755 cites W2089944837 @default.
• W1976264755 cites W2090518454 @default.
• W1976264755 cites W2095238078 @default.
• W1976264755 cites W2104041304 @default.
• W1976264755 cites W2104340251 @default.
• W1976264755 cites W2108931588 @default.
• W1976264755 cites W2110325808 @default.
• W1976264755 cites W2120977310 @default.
• W1976264755 cites W2131541226 @default.
• W1976264755 cites W4243149339 @default.
• W1976264755 doi "https://doi.org/10.1016/j.jvs.2008.12.044" @default.
• W1976264755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19563957" @default.
• W1976264755 hasPublicationYear "2009" @default.
• W1976264755 type Work @default.
• W1976264755 sameAs 1976264755 @default.
• W1976264755 citedByCount "15" @default.
• W1976264755 countsByYear W19762647552012 @default.
• W1976264755 countsByYear W19762647552014 @default.
• W1976264755 countsByYear W19762647552019 @default.
• W1976264755 countsByYear W19762647552021 @default.
• W1976264755 countsByYear W19762647552022 @default.
• W1976264755 crossrefType "journal-article" @default.
• W1976264755 hasAuthorship W1976264755A5034179596 @default.
• W1976264755 hasAuthorship W1976264755A5038834794 @default.
• W1976264755 hasAuthorship W1976264755A5041987541 @default.
• W1976264755 hasAuthorship W1976264755A5078212994 @default.
• W1976264755 hasAuthorship W1976264755A5086558284 @default.
• W1976264755 hasAuthorship W1976264755A5090747574 @default.
• W1976264755 hasBestOaLocation W19762647551 @default.
• W1976264755 hasConcept C126322002 @default.
• W1976264755 hasConcept C141071460 @default.
• W1976264755 hasConcept C164705383 @default.
• W1976264755 hasConcept C207103383 @default.
• W1976264755 hasConcept C2776782570 @default.
• W1976264755 hasConcept C2777391703 @default.
• W1976264755 hasConcept C2777466421 @default.
• W1976264755 hasConcept C2778963770 @default.
• W1976264755 hasConcept C2780221984 @default.
• W1976264755 hasConcept C2781099653 @default.
• W1976264755 hasConcept C3018348675 @default.
• W1976264755 hasConcept C44249647 @default.
• W1976264755 hasConcept C50382708 @default.
• W1976264755 hasConcept C511355011 @default.
• W1976264755 hasConcept C71924100 @default.
• W1976264755 hasConceptScore W1976264755C126322002 @default.
• W1976264755 hasConceptScore W1976264755C141071460 @default.
• W1976264755 hasConceptScore W1976264755C164705383 @default.
• W1976264755 hasConceptScore W1976264755C207103383 @default.
• W1976264755 hasConceptScore W1976264755C2776782570 @default.
• W1976264755 hasConceptScore W1976264755C2777391703 @default.
• W1976264755 hasConceptScore W1976264755C2777466421 @default.
• W1976264755 hasConceptScore W1976264755C2778963770 @default.
• W1976264755 hasConceptScore W1976264755C2780221984 @default.
• W1976264755 hasConceptScore W1976264755C2781099653 @default.
• W1976264755 hasConceptScore W1976264755C3018348675 @default.
• W1976264755 hasConceptScore W1976264755C44249647 @default.
• W1976264755 hasConceptScore W1976264755C50382708 @default.
• W1976264755 hasConceptScore W1976264755C511355011 @default.
• W1976264755 hasConceptScore W1976264755C71924100 @default.
• W1976264755 hasIssue "1" @default.
• W1976264755 hasLocation W19762647551 @default.
• W1976264755 hasLocation W19762647552 @default.
• W1976264755 hasOpenAccess W1976264755 @default.
• W1976264755 hasPrimaryLocation W19762647551 @default.
• W1976264755 hasRelatedWork W144503205 @default.
• W1976264755 hasRelatedWork W1982173900 @default.
• W1976264755 hasRelatedWork W1997445984 @default.
• W1976264755 hasRelatedWork W2066961600 @default.
• W1976264755 hasRelatedWork W2087512347 @default.
• W1976264755 hasRelatedWork W2112254863 @default.
• W1976264755 hasRelatedWork W2419327623 @default.
• W1976264755 hasRelatedWork W2467337626 @default.
• W1976264755 hasRelatedWork W2735536570 @default.
• W1976264755 hasRelatedWork W3207585776 @default.
• W1976264755 hasVolume "50" @default.

• next